Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its reactive bromoacetyl group allows for selective alkylation, enabling the formation of covalent bonds with target proteins. Commonly employed in medicinal chemistry for structure-activity relationship studies due to its ability to enhance binding affinity and selectivity. Also utilized in the preparation of labeled probes for biochemical assays and target validation.